Your browser doesn't support javascript.
loading
Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types.
van der Wijngaart, Hanneke; Hoes, Louisa R; van Berge Henegouwen, J Maxime; van der Velden, Daphne L; Zeverijn, Laurien J; Roepman, Paul; van Werkhoven, Erik; de Leng, Wendy W J; Jansen, Anne M L; Mehra, Niven; Robbrecht, Debbie G J; Labots, Mariette; de Groot, Derk Jan A; Hoeben, Ann; Hamberg, Paul; Gelderblom, Hans; Voest, Emile E; Verheul, Henk M W.
Afiliação
  • van der Wijngaart H; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Hoes LR; Oncode Institute, Utrecht, the Netherlands.
  • van Berge Henegouwen JM; Oncode Institute, Utrecht, the Netherlands.
  • van der Velden DL; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Zeverijn LJ; Oncode Institute, Utrecht, the Netherlands.
  • Roepman P; Department of Medical Oncology, Leiden University Medical Center, Rapenburg, Leiden, the Netherlands.
  • van Werkhoven E; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • de Leng WWJ; Oncode Institute, Utrecht, the Netherlands.
  • Jansen AML; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Mehra N; Hartwig Medical Foundation, Amsterdam, the Netherlands.
  • Robbrecht DGJ; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Labots M; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • de Groot DJA; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Hoeben A; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Hamberg P; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Gelderblom H; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Voest EE; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
  • Verheul HMW; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, the Netherlands.
Clin Cancer Res ; 27(22): 6106-6114, 2021 11 15.
Article em En | MEDLINE | ID: mdl-34475104
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda